Dr Ouyang has a multidisciplinary background in pharmaceutics & computer modelling, with experience in academia and industry. He obtained his bachelor (2000) and master (2005) in pharmaceutics from Shenyang Pharmaceutical University, China. He completed his PhD in pharmacy at The University of Queensland, Australia, in 2010 and progressed directly to his faculty position (Lecturer in Pharmaceutics, PI) at Aston University (UK). From the end of 2014, he moved to the University of Macau.

Since 2011, he has pioneered the integration of multi-scale modeling, artificial intelligence and big data techniques in the field of drug delivery – “computational pharmaceutics“. He has published 2 books, 5 book chapters and over 50 refereed SCI journal papers. He held 4 approved patents, which had been used in medicinal products. He edited the first book (John Wiley & Sons Inc., 2015) in this research area. He is invited to be the Editors-in-Chief of (Springer Nature) from January 2020. He also serves as the editorial board of and scientific advisor of . He is establishing the first global artificial intelligence (AI)-based formulation platform (www.computpharm.org). He successfully trained 4 PhD and 25 master. Currently his group includes 1 postdoctoral, 3 PhD students and 4 master students.